Bioprocess

Repligen Corporation to Present at 10th Annual SVB Leerink Healthcare Conference

Retrieved on: 
Monday, February 22, 2021
Repligen, Companies, SVB Leerink, Bioprocess, Waltham, Massachusetts

WALTHAM, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the 10thAnnual SVB Leerink Healthcare conference being held February 22-26.

Key Points: 
  • WALTHAM, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the 10thAnnual SVB Leerink Healthcare conference being held February 22-26.
  • Hunt, President and Chief Executive Officer, will participate in a fireside chat on Friday, February 26, at 12:00 p.m. EST.
  • Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs.
  • Our primary customers are biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide.

BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production

Retrieved on: 
Thursday, February 18, 2021
Pharmaceutical industry, Biotechnology, Contract manufacturing organization, Life sciences, Vaccine, Bioprocess, Biology

VANCOUVER, BC, Feb. 18, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") announced today that it has signed a Term Sheet ("Term Sheet") with BioElpida S.A.S.

Key Points: 
  • VANCOUVER, BC, Feb. 18, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") announced today that it has signed a Term Sheet ("Term Sheet") with BioElpida S.A.S.
  • ("BioElpida") of Lyon, France, to collaborate on the build-out for the clinical-grade manufacturing process and aseptic packaging for BXV-0918A, BioVaxys' vaccine for Stage III/Stage IV ovarian cancer.
  • BioElpida is a biotechnology contract development and manufacturing company ("CDMO") which applies single-use bioprocessing for development and manufacturing of biological and cell-based products.
  • This large group of non-responders to, or those who relapse after, first line therapy are the initial target market for BioVaxys.

BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production

Retrieved on: 
Thursday, February 18, 2021
Pharmaceutical industry, Biotechnology, Contract manufacturing organization, Life sciences, Vaccine, Bioprocess, Biology

VANCOUVER, BC, Feb. 18, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") announced today that it has signed a Term Sheet ("Term Sheet") with BioElpida S.A.S.

Key Points: 
  • VANCOUVER, BC, Feb. 18, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") announced today that it has signed a Term Sheet ("Term Sheet") with BioElpida S.A.S.
  • ("BioElpida") of Lyon, France, to collaborate on the build-out for the clinical-grade manufacturing process and aseptic packaging for BXV-0918A, BioVaxys' vaccine for Stage III/Stage IV ovarian cancer.
  • BioElpida is a biotechnology contract development and manufacturing company ("CDMO") which applies single-use bioprocessing for development and manufacturing of biological and cell-based products.
  • This large group of non-responders to, or those who relapse after, first line therapy are the initial target market for BioVaxys.

Two-third Single-use Bioprocess Systems Used for GMP and Commercial Production Applications: Persistence Market Research

Retrieved on: 
Wednesday, February 10, 2021
Biotechnology, Biological engineering, Articles, Biochemical engineering, Bioreactor, Bioprocess, Science and technology, Technology

Besides, continuous focus by key players to manufacture high quality and technologically-advanced disposable bioprocess systems is also expected to accelerate market growth.

Key Points: 
  • Besides, continuous focus by key players to manufacture high quality and technologically-advanced disposable bioprocess systems is also expected to accelerate market growth.
  • Increasing adoption of single-use bioprocess systems in biopharmaceutical companies is expected to result in remarkable revenue share of this segment.
  • Get Full Access of Report: https://www.persistencemarketresearch.com/checkout/12142
    Key market players in the single-use bioprocess systems market are looking forward to expanding their manufacturing capacities by establishing new bioprocess facilities to meet global demand.
  • Persistence Market Research offers actionable insights and unique perspective on the single-use bioprocess systems market in its latest study, presenting historical demand assessment of 2015 2019 and projections for 20202030, based on component (bioreactors, mixers, bioprocess containers, transfer and storage bags, sampling systems, filtration systems, chromatography columns, probes & sensors, tubing assemblies, connectors & clamps, and filling systems), application (research & development (R&D) and GMP and commercial production), and end user (biopharmaceutical companies, contract research organizations, contract manufacturing organizations, and research institutes), across seven key regions of the world.

Two-third Single-use Bioprocess Systems Used for GMP and Commercial Production Applications: Persistence Market Research

Retrieved on: 
Wednesday, February 10, 2021
Biotechnology, Biological engineering, Articles, Biochemical engineering, Bioreactor, Bioprocess, Science and technology, Technology

Besides, continuous focus by key players to manufacture high quality and technologically-advanced disposable bioprocess systems is also expected to accelerate market growth.

Key Points: 
  • Besides, continuous focus by key players to manufacture high quality and technologically-advanced disposable bioprocess systems is also expected to accelerate market growth.
  • Increasing adoption of single-use bioprocess systems in biopharmaceutical companies is expected to result in remarkable revenue share of this segment.
  • Get Full Access of Report: https://www.persistencemarketresearch.com/checkout/12142
    Key market players in the single-use bioprocess systems market are looking forward to expanding their manufacturing capacities by establishing new bioprocess facilities to meet global demand.
  • Persistence Market Research offers actionable insights and unique perspective on the single-use bioprocess systems market in its latest study, presenting historical demand assessment of 2015 2019 and projections for 20202030, based on component (bioreactors, mixers, bioprocess containers, transfer and storage bags, sampling systems, filtration systems, chromatography columns, probes & sensors, tubing assemblies, connectors & clamps, and filling systems), application (research & development (R&D) and GMP and commercial production), and end user (biopharmaceutical companies, contract research organizations, contract manufacturing organizations, and research institutes), across seven key regions of the world.

Increased Research Activities Boost Demand Opportunities in Bioprocess Analyzers Market: TMR

Retrieved on: 
Tuesday, February 2, 2021
Biotechnology, Bioprocess

Analysts at Transparency Market Research state that the global bioprocess analyzers market is foreseen to gain the valuation of US$ 600 Mn by the end of 2027.

Key Points: 
  • Analysts at Transparency Market Research state that the global bioprocess analyzers market is foreseen to gain the valuation of US$ 600 Mn by the end of 2027.
  • Owing to this factor, the global bioprocess analyzers market is expected to show lucrative avenues in the forthcoming years.
  • Based on end-user, the bioprocess analyzers market is foreseen to gain prodigious growth opportunities from contract manufacturing organization segment.
  • This scenario is expected to fuel the expansion of the global bioprocess analyzers market in the years to come.

Increased Research Activities Boost Demand Opportunities in Bioprocess Analyzers Market: TMR

Retrieved on: 
Tuesday, February 2, 2021
Biotechnology, Bioprocess

Analysts at Transparency Market Research state that the global bioprocess analyzers market is foreseen to gain the valuation of US$ 600 Mn by the end of 2027.

Key Points: 
  • Analysts at Transparency Market Research state that the global bioprocess analyzers market is foreseen to gain the valuation of US$ 600 Mn by the end of 2027.
  • Owing to this factor, the global bioprocess analyzers market is expected to show lucrative avenues in the forthcoming years.
  • Based on end-user, the bioprocess analyzers market is foreseen to gain prodigious growth opportunities from contract manufacturing organization segment.
  • This scenario is expected to fuel the expansion of the global bioprocess analyzers market in the years to come.

Contract Research Organizations (CRO) Market by Services, Therapeutic Area, End-user and Geography - Global Forecast to 2027

Retrieved on: 
Monday, January 11, 2021
Life sciences, Biotechnology, Articles, Health sciences, Pharmaceutical industry, Pharmaceuticals policy, Clinical research, Contract research organization, Biopharmaceutical, Bioprocess, Market, Pharmaceutical industry in India

The global contract research organizations market is expected to grow at a CAGR of 6.5% from 2020 to 2027 to reach $64.4 billion by 2027.

Key Points: 
  • The global contract research organizations market is expected to grow at a CAGR of 6.5% from 2020 to 2027 to reach $64.4 billion by 2027.
  • The growth in the contract research organizations market is mainly attributed to the rising demand for biopharmaceuticals, an increasing number of clinical trials, and growing government support for biopharmaceutical manufacturing.
  • Moreover, opportunities from emerging markets, increasing demand for biosimilars, and continuous advancements in bioprocessing techniques offer significant opportunities for players operating in the contract research organizations market.
  • North America commanded the largest share of the global contract research organizations market in 2019, followed by Asia-Pacific, Europe, Latin America, and the Middle East & Africa.

Global Contract Research Organizations Market (2020 to 2027) - Increasing Demand for Biosimilars Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Friday, January 8, 2021
Health, Clinical trials, Research, Pharmaceutical, Science, Biotechnology, Life sciences, Biotechnology, Articles, Health sciences, Pharmaceutical industry, Pharmaceuticals policy, Clinical research, Contract research organization, Biopharmaceutical, Bioprocess, Market, Pharmaceutical industry in India

The global contract research organizations market is expected to grow at a CAGR of 6.5% from 2020 to 2027 to reach $64.4 billion by 2027.

Key Points: 
  • The global contract research organizations market is expected to grow at a CAGR of 6.5% from 2020 to 2027 to reach $64.4 billion by 2027.
  • The growth in the contract research organizations market is mainly attributed to the rising demand for biopharmaceuticals, an increasing number of clinical trials, and growing government support for biopharmaceutical manufacturing.
  • Moreover, opportunities from emerging markets, increasing demand for biosimilars, and continuous advancements in bioprocessing techniques offer significant opportunities for players operating in the contract research organizations market.
  • North America commanded the largest share of the global contract research organizations market in 2019, followed by Asia-Pacific, Europe, Latin America, and the Middle East & Africa.

Improving Cell Culture Process Control While Maintaining Quality of Biologics, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Friday, January 8, 2021
Life sciences, Biotechnology, Biology, Articles, Biopharmaceutical, Cell culture, Bioprocess

However, traditional process control methods are often the rate-limiting steps in cell culture and are counter-productive to the aim of continuous processing of biologics.

Key Points: 
  • However, traditional process control methods are often the rate-limiting steps in cell culture and are counter-productive to the aim of continuous processing of biologics.
  • This webinar will discuss methods for implementing real-time measurement of cell culture parameters to improve process control and achieve better productivity.
  • The expert speaker will cover key upstream bioprocessing analytical requirements during suspension and adherent cell culture and explain how to meet those requirements using three key sensors.
  • For more information, or to register for this event, visit Improving Cell Culture Process Control While Maintaining Quality of Biologics.